JF
ZYME icon

Jump Financial’s Zymeworks ZYME Stock Holding History

Jump Financial’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-48,612
Closed -$712K – 2089
2024
Q4 		$712K Buy
+48,612
New +$680K 0.01% 914
2024
Q3 		– Sell
-45,769
Closed -$389K – 2190
2024
Q2 		$389K Buy
+45,769
New +$407K 0.01% 1245
2023
Q2 		– Sell
-95,311
Closed -$862K – 2231
2023
Q1 		$862K Buy
95,311
+63,424
+199% +$553K 0.04% 661
2022
Q4 		$251K Buy
+31,887
New +$224K 0.01% 1153
2022
Q3 		– Sell
-55,500
Closed -$294K – 2041
2022
Q2 		$294K Buy
55,500
+11,152
+25% +$67.4K 0.01% 1081
2022
Q1 		$290K Buy
+44,348
New +$395K 0.01% 1083
2021
Q4 		– Sell
-33,841
Closed -$983K – 1778
2021
Q3 		$983K Buy
+33,841
New +$1.12M 0.07% 297
2021
Q2 		– Sell
-19,142
Closed -$604K – 1436
2021
Q1 		$604K Buy
+19,142
New +$778K 0.06% 353

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jump Financial's ZYME Position: Q1 2025 in Review

Jump Financial sold out of Zymeworks (ZYME) in Q1 2025, closing a stake of 48,612 shares — an estimated $712K sold.

Jump Financial first reported a position in ZYME in Q1 2021 and held it in 8 quarters. The position peaked at $983K in Q3 2021. 184 funds tracked by Wall St. Rank hold ZYME as of Q1 2025.

  • Jump Financial reported no remaining Zymeworks position as of Q1 2025 after selling out during the quarter.
  • Jump Financial sold 48,612 Zymeworks shares in Q1 2025, an estimated $712K.
  • Jump Financial first reported a position in Zymeworks in Q1 2021 and held it in 8 quarters.
  • Jump Financial's Zymeworks position peaked at $983K in Q3 2021.
  • 184 funds tracked by Wall St. Rank held Zymeworks as of Q1 2025.

Based on Jump Financial's 13F filing for Q1 2025, filed 14 May 2025.